XOVR Research Note — The Wrapper Still Needs Proof
XOVR recovered above its long-term trend, while inconsistent private marks leave its modest discount and SpaceX pass-through question unresolved.
XOVR
XOVR Deep Coverage Review — Analysis as of August 13, 2026
XOVR trades near a modest discount, but private marks and a short SpaceX evidence record keep the wrapper’s central valuation question unresolved.
XOVR Research Note — The Proxy Faces Live Transmission
XOVR’s August decline suggests SpaceX volatility is reaching the wrapper, with additional supply events keeping redemption resilience in focus.
XOVR Deep Coverage Review — Analysis as of August 6, 2026
XOVR’s decline suggests SpaceX volatility now transmits into the wrapper while a multi-month supply calendar keeps fund resilience under review.
XOVR Research Note — Scarcity Meets a Longer Supply Test
XOVR’s SpaceX exposure is smaller, but weak market structure and unresolved fund flows raise the stakes around the August supply window ahead.
XOVR Deep Coverage Review — Analysis as of July 30, 2026
XOVR’s SpaceX access now meets weak market structure, unresolved fund flows and a multi-tranche supply calendar beginning August 6, 2026, and beyond.
XOVR Research Note — Private-Market Access Meets a Catalyst
XOVR’s scarce SpaceX access comes with private-mark uncertainty and correlated growth exposure ahead of a concentrated August catalyst window.
XOVR Deep Coverage Review — Analysis as of July 22, 2026
XOVR combines scarce SpaceX access with public-growth concentration, making August supply, private marks and long-term structure decisive now.